Snider, N. T., Nast, J. A., Tesmer, L. A., & Hollenberg, P. F. (2009). A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist. American Society for Pharmacology and Experimental Therapeutics.
Citación estilo ChicagoSnider, Natasha T., James A. Nast, Laura A. Tesmer, and Paul F. Hollenberg. A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is A Potent Cannabinoid Receptor 2-Selective Agonist. American Society for Pharmacology and Experimental Therapeutics, 2009.
Cita MLASnider, Natasha T., James A. Nast, Laura A. Tesmer, and Paul F. Hollenberg. A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is A Potent Cannabinoid Receptor 2-Selective Agonist. American Society for Pharmacology and Experimental Therapeutics, 2009.